AnPac Bio-Medical Science Co. Ltd. (ANPC) |
|
3.89 -0.31 (-7.38%)
|
09-29 00:57 |
|
Open: |
4.25 |
Pre. Close: |
4.2 |
|
High:
|
4.25 |
Low:
|
3.65 |
|
Volume:
|
56,007 |
Market Cap:
|
44M |
|
|
|
|
AnPac Bio-Medical Science Co., Ltd. is a China-based biotechnology company focused on early cancer screening and detection. The Company markets and sells multi-cancer screening and detection test that uses cancer differentiation analysis (CDA), technology and its cancer-detection device or CDA device. In addition to early cancer screening and detection, its CDA technology assists physicians in cancer diagnosis, prognosis and recurrence. Its CDA technology provides a platform on which it has developed cancer screening and detection test using its CDA technology, or CDA test, and its CDA device. Its CDA technology focuses on biophysical properties in human blood. The Company have established two clinical laboratories in China and one clinical laboratory in the United States. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
4.256 - 4.286 |
4.286 - 4.309 |
|
Low:
|
3.581 - 3.617 |
3.617 - 3.644 |
|
Close:
|
3.838 - 3.889 |
3.889 - 3.928 |
|
Technical analysis |
as of: 2020-09-28 4:29:49 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 6.13  One year: 7.28 |
| Support: |
Support1: 3.65 Support2: 3.04 |
| Resistance: |
Resistance1: 5.25 Resistance2: 6.23 |
| Pivot: |
4.65 |
| Moving Average: |
MA(5): 4.42 MA(20): 4.78
MA(100): 6.27 MA(250): |
| MACD: |
MACD(12,26): -0.39 Signal(9): -0.35 |
| Stochastic oscillator: |
%K(14,3): 8.31 %D(3): 13.82 |
| RSI: |
RSI(14): 32.44 |
| 52-week: |
High: 12.00 Low: 3.65 Change(%): -65.4 |
| Average Vol(K): |
3-Month: 33608 10-Days: 10206 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ANPC has closed below the lower band by 11.4%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 31.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 25 Sep 2020
AnPac Bio-Medical Science Co., Ltd (ANPC) Q2 2020 Earnings Call Transcript - AlphaStreet
Wed, 23 Sep 2020
Breaking News: Tiger Asia Intelligence reiterates a Buy rating on AnPac Bio, Ltd (NASDAQ:ANPC) - Financialbuzz.com
Thu, 17 Sep 2020
Is AnPac Bio-Medical Science Co Ltd - ADR (ANPC) Stock Worth a Buy Thursday? - InvestorsObserver
Tue, 15 Sep 2020
AnPac Bio Receives Major Immunology Testing Contract - GlobeNewswire
Tue, 15 Sep 2020
“Buzz on the Street” Show: AnPac Bio-Medical (NASDAQ: ANPC) Receives Immunology Testing Contract - Financialbuzz.com
Thu, 10 Sep 2020
AnPac Bio Reports First Six Months of 2020 Financial Results - Yahoo Finance
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Neutral |
Discounted cash flow: |
Neutral |
| Return on Assets: |
Neutral |
Price to Earnings: |
Neutral |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
11 |
| Shares Float (M) |
2 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
0.02 |
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
8 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
|
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
3.4 |
|
Gross Profit (p.s.)
|
0.429 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
|
|
Price to Cash Flow
|
|
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
